Status:
COMPLETED
Pulmonary Complications of Hematopoietic Stem Cell Transplantation
Lead Sponsor:
Karen Wood
Conditions:
Lung Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine risk factors associated with the development of lung disease after hematopoietic stem cell transplantation. Depending on the results and findings of this stud...
Detailed Description
The development of pulmonary complications after hematopoietic stem cell transplantation is responsible for significant morbidity and mortality. The incidence of pulmonary disease has been reported to...
Eligibility Criteria
Inclusion
- 1\. All patients scheduled to undergo hematopoietic stem cell transplantation (HSCT)
Exclusion
- Patients whose ability to give informed consent is in question.
- Pregnancy.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 8 2016
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00837681
Start Date
October 1 2005
End Date
July 8 2016
Last Update
February 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43210